Wednesday, Jan 8, 2025 · SEC filings

What the smart money revealed on Jan 8

Real insider buys24insiders · $2.19M
Real insider sales54insiders · $182M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

462 insider filings came in. We hid 96 planned (10b5-1) sellers and 265 people whose filings were routine, like grants and tax withholding.

group

6 insiders at Carlyle Secured Lending III bought $203K of stock

Roles: CEO, CFO, VP, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Jan 7
$203K
group

6 insiders at Acurx Pharmaceuticals (ACXP) bought $171K of stock

Roles: CEO, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Jan 6
$171K
group

3 insiders at Amesite (AMST) bought $1.26M of stock

Roles: CEO, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Jan 7
$1.26M
trending_up

FedEx (FDX) EVP Chief Financial OFF John Dietrich bought $274K

1,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 7
$274K
trending_up

Lifecore Biomedical (LFCR) CEO Paul Josephs bought $97.6K

17,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 8
$97.6K
trending_up

Central Securities (CET) Vice President Andrew O'Neill bought $59.8K

1,309 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 4 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 3 of 4 beat Traded Jan 6
$59.8K
trending_down

Dell Technologies (DELL) Director Egon Durban sold $100M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 418,331 shares directly.

Real sale Form 4 Traded Jan 7–8
$100M
trending_down

Dick's Sporting Goods (DKS) Executive Chairman Edward Stack sold $36.8M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 8.36M shares directly.

Real sale Form 4 Traded Jan 6
$36.8M
trending_down

Celestica (CLS) Director Michael Wilson sold $2.47M

Not marked as a planned 10b5-1 sale. Sold 93% of the shares they held directly. Still holds 1,784 shares.

Real sale Form 4 Sold 93% of stake Traded Jan 6
$2.47M
Show 6 more real buys
Show 51 more real sales
CRDO Credo Technology Group Holding · Director Lip Tan · Traded Jan 6
$11.4M
AVGO Broadcom · Director Check Low · Traded Jan 6
$11.3M
RBRK Rubrik · Chief Revenue Officer Brian McCarthy · Traded Jan 7
$4.33M
INTU Intuit · EVP Laura Fennell · Traded Jan 7
$2.94M
NCNO nCino · Director Jeff Horing · Traded Jan 6
$1.92M
DRI Darden Restaurants · SVP Susan Connelly · Traded Jan 6
$1.71M
CPT Camden Property Trust · President and CFO Alexander Jessett · Traded Jan 6–8
$1.7M
CIEN Ciena · Director Bruce Claflin · Traded Jan 6
$1.44M
CPT Camden Property Trust · Chairman and CEO Richard Campo · Traded Jan 6–8
$953K
DNLI Denali Therapeutics · President and CEO Ryan Watts · Traded Jan 6–7
$751K
MRVL Marvell Technology · Director Michael Strachan · Traded Jan 6
$613K
MIRM Mirum Pharmaceuticals · CEO Christopher Peetz · Traded Jan 7
$321K
DNLI Denali Therapeutics · COFO and Secretary Alexander Schuth · Traded Jan 6–7
$308K
DNLI Denali Therapeutics · Chief Medical Officer Carole Ho · Traded Jan 6–7
$308K
PLAB Photronics · SVP and GM of FPD Ops Han Park · Traded Jan 7
$277K
CPT Camden Property Trust · Director Heather Brunner · Traded Jan 6–8
$241K
NEUE NeueHealth · CEO and President George Mikan III · Traded Jan 6
$233K
AMBA Ambarella · COO Chan Lee · Traded Jan 6–8
$231K
GTI Graphjet Technology · Director Swee Hoo · Traded Jan 6–7
$224K
BRZE Braze · Chief Accounting Officer Pankaj Malik · Traded Jan 6
$169K
TRAK ReposiTrak · CEO Randall Fields · Traded Jan 6–7
$162K
PHR Phreesia · CEO Chaim Indig · Traded Jan 6
$143K
BB Blackberry · CEO and President John Giamatteo · Traded Jan 6
$118K
PHR Phreesia · General Counsel and Secretary Allison Hoffman · Traded Jan 6
$106K
APLS Apellis Pharmaceuticals · Chief Medical Officer Caroline Baumal · Traded Jan 6
$95.2K
MIRM Mirum Pharmaceuticals · President and COO Peter Radovich · Traded Jan 7
$85.6K
PHR Phreesia · CFO Balaji Gandhi · Traded Jan 6
$85K
PHR Phreesia · SVP David Linetsky · Traded Jan 6
$83.4K
DNLI Denali Therapeutics · Director Steve Krognes · Traded Jan 7
$69.5K
IAS Integral Ad Science Holding · CEO Lisa Utzschneider · Traded Jan 7
$57.9K
BB Blackberry · President of IoT Mattias Eriksson · Traded Jan 6
$50.7K
GEF Greif · EVP Bala Sathyanarayanan · Traded Jan 8
$45K
GE General Electric · Senior Vice President Rahul Ghai · Traded May 9–10
$43.7K
NEUE NeueHealth · CFO Jay Matushak · Traded Jan 6
$36.4K
PHR Phreesia · SVP Amy VanDuyn · Traded Jan 6
$34.9K
MIRM Mirum Pharmaceuticals · SVP Jolanda Howe · Traded Jan 7
$32.1K
PEBO Peoples Bancorp · Director Carol Schneeberger · Traded Jan 8
$31K
AMLX Amylyx Pharmaceuticals · Co-CEO Joshua Cohen · Traded Jan 6
$30.3K
AMLX Amylyx Pharmaceuticals · Co-CEO Justin Klee · Traded Jan 6
$30.2K
BB Blackberry · Chief Gv Aff and Pub Pol Officer Marjorie Dickman · Traded Jan 6
$22.9K
NEUE NeueHealth · GC and Corporate Secretary Jeffery Craig · Traded Jan 6
$18.2K
NEUE NeueHealth · Chief Accounting Officer Jeffrey Scherman · Traded Jan 6
$10K
NEUE NeueHealth · EVP Tomas Orozco · Traded Jan 6
$9.04K
BB Blackberry · SVP and Chief Accounting Officer Jay Chai · Traded Jan 6
$8.27K
DNA Ginkgo Bioworks · Officer Mark Dmytruk · Traded Jan 6
$7.56K
ALXO ALX Oncology · Interim CFO Shelly Pinto · Traded Jan 6
$4K
DNA Ginkgo Bioworks · Officer Steven Coen · Traded Jan 6
$3.8K
CBUS Cibus · Director Gerhard Prante · Traded Jan 7
$3.52K
BB Blackberry · CFO Tim Foote · Traded Jan 6
$2.98K
GRDX Entero Therapeutics · CFO Sarah Romano · Traded Jan 6
$465
VSTM Verastem · CFO Daniel Calkins · Traded Jan 6
$42

13F season

Holdings as of Dec 31, 2024 are due Feb 14

81 funds have filed so far. 58 filed for the quarter before.

Biggest real insider buys, Jan 2–8

Open-market buys by officers and directors, filed in the 7 days up to Jan 8.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist